• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人中的地高辛:衰老对药代动力学的影响

Digoxin in the elderly: pharmacokinetic consequences of old age.

作者信息

Cusack B, Kelly J, O'Malley K, Noel J, Lavan J, Horgan J

出版信息

Clin Pharmacol Ther. 1979 Jun;25(6):772-6. doi: 10.1002/cpt1979256772.

DOI:10.1002/cpt1979256772
PMID:445943
Abstract

A study of single-dose digoxin kinetics was performed in 6 young and 7 elderly patients. The rate of absorption, determined by the time to peak concentration after an oral dose, was more rapid in the younger group. The extent of absorption, as measured by comparison of the area under the plasma concentration/time curve after oral and intravenous administration, was similar in both groups. Mean plasma half-life was longer and individual values were more variable in the elderly patients. The absolute apparent volume of distribution was reduced in the older patients and correlated inversely with age. When corrected for weight, however, the difference in the apparent volume of distribution did not approach significance. Both absolute and weight-corrected values for plasma clearance of digoxin were reduced in the elderly subjects.

摘要

对6名年轻患者和7名老年患者进行了单剂量地高辛动力学研究。通过口服给药后达到峰值浓度的时间确定的吸收速率,在年轻组中更快。通过比较口服和静脉给药后血浆浓度/时间曲线下的面积来衡量的吸收程度,在两组中相似。老年患者的平均血浆半衰期较长,个体值的变异性更大。老年患者的绝对表观分布容积减小,且与年龄呈负相关。然而,校正体重后,分布容积的差异无统计学意义。老年受试者地高辛的血浆清除率的绝对值和校正体重后的值均降低。

相似文献

1
Digoxin in the elderly: pharmacokinetic consequences of old age.老年人中的地高辛:衰老对药代动力学的影响
Clin Pharmacol Ther. 1979 Jun;25(6):772-6. doi: 10.1002/cpt1979256772.
2
Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects.
J Cardiovasc Pharmacol. 1987 Apr;9(4):385-90. doi: 10.1097/00005344-198704000-00001.
3
[Effect of age on the pharmacokinetic parameters of digoxin].
Farmakol Toksikol. 1984 May-Jun;47(3):101-4.
4
[Pharmacokinetics of digoxin in middle-aged and elderly patients in the subacute period of myocardial infarction].[地高辛在心肌梗死亚急性期中年及老年患者中的药代动力学]
Kardiologiia. 1986 May;26(5):33-6.
5
Pharmacokinetic studies of nifedipine and digoxin co-administration.
Int J Clin Pharmacol Ther Toxicol. 1986 Jan;24(1):39-42.
6
Assessment of the potential pharmacokinetic interaction between digoxin and ethmozine.
J Clin Pharmacol. 1985 Mar;25(2):138-43. doi: 10.1002/j.1552-4604.1985.tb02814.x.
7
A pharmacokinetic study of digoxin in the horse.洋地黄毒苷在马体内的药代动力学研究。
J Vet Pharmacol Ther. 1983 Sep;6(3):163-72. doi: 10.1111/j.1365-2885.1983.tb00460.x.
8
Absorption of digoxin from different oral preparations in normal subjects during steady state.
Clin Pharmacol Ther. 1974 Aug;16(2):310-7. doi: 10.1002/cpt1974162310.
9
Assessment of methodology in single-dose studies of digoxin bioavailability.
Pharmacology. 1976;14(2):182-90. doi: 10.1159/000136593.
10
Absolute bioavailability of digoxin tablets.地高辛片的绝对生物利用度。
Arzneimittelforschung. 1978;28(4):701-3.

引用本文的文献

1
Age-related modifications in CYP-dependent drug metabolism: role of stress.与年龄相关的 CYP 依赖性药物代谢的改变:应激的作用。
Front Endocrinol (Lausanne). 2023 May 24;14:1143835. doi: 10.3389/fendo.2023.1143835. eCollection 2023.
2
Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly.基于生理学的药代动力学模型识别导致老年人药物暴露变化的药代动力学参数。
Clin Pharmacokinet. 2020 Mar;59(3):383-401. doi: 10.1007/s40262-019-00822-9.
3
Accidental Intrathecal Administration of Digoxin in an Elderly Male with End-Stage Renal Disease.
一名终末期肾病老年男性意外鞘内注射地高辛
Case Rep Neurol Med. 2017;2017:9072018. doi: 10.1155/2017/9072018. Epub 2017 Aug 22.
4
Use of antiarrhythmic drugs in elderly patients.老年患者抗心律失常药物的应用。
J Geriatr Cardiol. 2011 Sep;8(3):184-94. doi: 10.3724/SP.J.1263.2011.00184.
5
The pharmacokinetics of oxypurinol in people with gout.黄嘌呤醇在痛风患者中的药代动力学。
Br J Clin Pharmacol. 2012 Sep;74(3):477-89. doi: 10.1111/j.1365-2125.2012.04207.x.
6
Is antiarrhythmic treatment in the elderly different? a review of the specific changes.老年人的抗心律失常治疗是否不同?对具体变化的综述。
Drugs Aging. 2011 Aug 1;28(8):617-33. doi: 10.2165/11591680-000000000-00000.
7
Pharmacokinetic considerations for digoxin in older people.老年人地高辛的药代动力学考量
Open Cardiovasc Med J. 2011;5:130-5. doi: 10.2174/1874192401105010130. Epub 2011 Jun 15.
8
Beers-Fick criteria and drugs available through the Farmácia Dose Certa program.《Beers - Fick标准》以及通过“精准剂量药房”计划可获取的药物。
Sao Paulo Med J. 2011 Jan 6;129(1):17-22. doi: 10.1590/s1516-31802011000100004.
9
The geriatric population and psychiatric medication.老年人群与精神科药物
Mens Sana Monogr. 2010 Jan;8(1):30-51. doi: 10.4103/0973-1229.58818.
10
Polypharmacy in the Elderly: Drug reactions and interaction in the aged.老年人的多种药物治疗:老年人的药物反应和相互作用。
Can Fam Physician. 1991 Jan;37:120-4.